US stock listed company Artelo Biosciences announced a $9.475 million private placement plan to establish a Solana treasury strategy

TechFlame

2025-09-09 08:41

TechFlame2025-09-09 08:41

English

On September 3, according to Investing.com, biotech company Artelo Biosciences (NASDAQ: ARTL) announced a $9.475 million private funding plan to launch a Solana-based reserve strategy, according to Investing.com. Currently, Artelo Biosciences has a market cap of $11.4 million and shares at $8.76